Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Johnson and Johnson
Fish and Richardson
Express Scripts
Federal Trade Commission
Cantor Fitzgerald

Generated: June 28, 2017

DrugPatentWatch Database Preview

ISORDIL Drug Profile

« Back to Dashboard

What is the patent landscape for Isordil, and what generic Isordil alternatives are available?

Isordil is a drug marketed by Biovail, Wyeth Ayerst, and Valeant Pharms North. and is included in three NDAs.

The generic ingredient in ISORDIL is isosorbide dinitrate. There are thirty-seven drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.

Summary for Tradename: ISORDIL

Suppliers / Packagers: see list1
Bulk Api Vendors: see list33
Clinical Trials: see list2
Patent Applications: see list4,471
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ISORDIL at DailyMed

Pharmacology for Tradename: ISORDIL

Drug ClassNitrate Vasodilator
Physiological EffectVasodilation
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
isosorbide dinitrate
TABLET;SUBLINGUAL012940-004Jul 29, 1988DISCNYesNo► Subscribe► Subscribe
Valeant Pharms North
isosorbide dinitrate
TABLET;ORAL012093-002Jul 29, 1988DISCNYesNo► Subscribe► Subscribe
Wyeth Ayerst
isosorbide dinitrate
CAPSULE, EXTENDED RELEASE;ORAL012882-002Jul 29, 1988DISCNNoNo► Subscribe► Subscribe
Valeant Pharms North
isosorbide dinitrate
TABLET;ORAL012093-006Jul 29, 1988DISCNYesNo► Subscribe► Subscribe
isosorbide dinitrate
TABLET;SUBLINGUAL012940-003Jul 29, 1988DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Cantor Fitzgerald
Harvard Business School
Federal Trade Commission
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus